Correvio Pharma (CORV) Inventory Turnover Ratio, from fourth quarter 2019 to fourth quarter 2018, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Correvio Pharma Corp   (CORV)
 

Correvio Pharma Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Correvio Pharma Corp inventory turnover ratio, the Correvio Pharma Corp 's ability to sell and replace its inventory in the fourth quarter 2019, sequentially increased to 2.95 in the fourth quarter 2019, yet the ratio remained below the average, as CORV's market remain challenging.Average inventory processing period, for the Correvio Pharma in Dec 31 2019 quarter, has decreased to 124 days, compare to 154 days, in the 0 quarter.

Within Healthcare sector 132 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2019, to 1563, from total ranking in the third quarter 2019 at 1579.

CORV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Correvio Pharma Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CORV Inventory Turnover Ratio (Dec 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Inventory Growth -20.38 % -14.31 % -14.31 % -14.31 % -28.69 %
Y / Y Cost of Sales Growth 18.48 % - - - 22.4 %
Inventory Turnover Ratio (TTM) 2.95 - - - 2.1
CORV's Total Ranking # 1563 # 1579 # 1582 # 1562 # 1622
Average inventory processing period 124 - - - 173
Seq. Inventory Growth -26.52 % 0 % 0 % 8.36 % -20.92 %
Seq. Cost of Sales Growth - - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 39
Healthcare Sector # 133
Overall Market # 1563

Inventory Turnover Ratio Statistics
High Average Low
5.52 3.35 0.48
(Dec 31 2014)   (Dec 31 2013)



CORV Company Profile >> Back to CORV Efficiency Comparisons >> Compare CORV Inventory Turnover Ratio to its Competitors

Financial Statements
Correvio Pharma 's Inventories $ 3 Millions Visit CORV's Balance sheet
Correvio Pharma 's Cost of Revenues TTM $ 10 Millions Visit CORV's Income Statement
What are CORV's Sales? Visit CORV's Sales by Segment

Other Inventory Turnover Ratios
Correvio Pharma 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CORV's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CORV's Competitors
Inventory Turnover Ratio for CORV's Suppliers
Inventory Turnover Ratio for CORV's Customers

You may also want to know
CORV's Sales Growth Rates CORV's Pe Price to earnings ratio CORV's Receivables Turnover Ratio CORV's Stock Quote
CORV's Net Income Growth Rates CORV's Ps Price to Sales ratio CORV's Sales per Employee CORV's Asset Turnover Ratio
CORV's Net Margin CORV's Pb Price to Book ratio CORV's Financial Strength Ratios CORV's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2019 Inventories at quarter ending Dec 31 2019
Avalo Therapeutics Inc   10.23 $ 5.340  Millions$ 1  Millions
Viemed Healthcare Inc   9.75 $ 24.250  Millions$ 2  Millions
Steris Plc  9.66 $ 1,685.538  Millions$ 175  Millions
Charles River Laboratories International inc   9.45 $ 1,371.699  Millions$ 145  Millions
Musclepharm Corporation  9.42 $ 70.979  Millions$ 8  Millions
Natera Inc   9.18 $ 123.682  Millions$ 13  Millions
Amarin Corp Plcuk  8.39 $ 96.019  Millions$ 11  Millions
Castle Biosciences Inc   8.37 $ 7.310  Millions$ 1  Millions
Biocardia Inc   8.33 $ 0.358  Millions$ 0  Millions
Perspective Therapeutics Inc   8.15 $ 4.264  Millions$ 1  Millions
Bionexus Gene Lab Corp   8.03 $ 0.071  Millions$ 0  Millions
Twist Bioscience Corporation  8.02 $ 49.361  Millions$ 6  Millions
Kewaunee Scientific Corporation  7.61 $ 124.649  Millions$ 16  Millions
Ufp Technologies Inc   7.60 $ 144.422  Millions$ 19  Millions
Caredx Inc   7.59 $ 42.560  Millions$ 6  Millions
Nexgel Inc   7.51 $ 0.854  Millions$ 0  Millions
Enzo Biochem Inc  7.48 $ 57.031  Millions$ 8  Millions
Align Technology inc   7.44 $ 662.899  Millions$ 89  Millions
Htg Molecular Diagnostics Inc  7.42 $ 8.911  Millions$ 1  Millions
Catalent Inc   7.42 $ 1,864.200  Millions$ 251  Millions
National Vision Holdings Inc   7.06 $ 806.519  Millions$ 114  Millions
Carlisle Companies Incorporated  7.01 $ 3,439.900  Millions$ 491  Millions
Avid Bioservices Inc   6.92 $ 55.328  Millions$ 8  Millions
Fonar Corporation  6.88 $ 12.295  Millions$ 2  Millions
Advanced Container Technologies Inc   6.86 $ 1.021  Millions$ 0  Millions
Horizon Therapeutics Public Limited Company  6.74 $ 362.175  Millions$ 54  Millions
Omnova Solutions Inc  6.73 $ 560.000  Millions$ 83  Millions
Vericel Corporation  6.68 $ 37.571  Millions$ 6  Millions
Veracyte Inc   6.48 $ 36.077  Millions$ 6  Millions
Harrow Inc   6.21 $ 16.749  Millions$ 3  Millions

Date modified: 2026-09-08T15:09:54+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.